Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Advanced BioNutrition Is Worldwide Exclusive Licensee of Newly Issued Patent for Production of DHA; U.S. Patent Issued to University of Hull (GB) and Wageningen University (NL).


COLUMBIA, Md. -- Advanced BioNutrition Corp. (ABN) announced today that it is the worldwide exclusive licensee of a patent issued to the University of Hull (GB) and the Agrotechnology & Food Sciences Group (AFSG AFSG Amphibious Force Support Group (USN/USMC) ) of Wageningen University and Research Centre (previously known as ATO ATO Australian Taxation Office
ATO Ambito Territoriale Ottimale (Italy)
ATO Alpha Tau Omega
ATO Air Traffic Organization (FAA)
ATO Arab Towns Organization
ATO Air Tasking Order
ATO Assemble To Order
) (NL) on December 20, 2005. The U.S. patent (#6,977,166), entitled "Method of Producing an Oil Including Docosahexaenoic Acid docosahexaenoic acid /do·co·sa·hexa·eno·ic ac·id/ (do-ko?sah-hek?sah-e-no´ik) an omega-3, polyunsaturated, 22-carbon fatty acid found almost exclusively in fish and marine animal oils. ," describes a novel method for producing an oil containing docosahexaenoic acid (DHA DHA docosahexaenoic acid.
DHA,
n.pr See acid, docosahexaenoic.
) by fermentation of the microalgae Crypthecodinium cohnii. This method involves the use of efficient semi-continuous and continuous production methods and a low cost fermentation substrate to produce algae algae (ăl`jē) [plural of Lat. alga=seaweed], a large and diverse group of primarily aquatic plantlike organisms. These organisms were previously classified as a primitive subkingdom of the plant kingdom, the thallophytes (plants that  containing high levels of a DHA-rich oil. The patent has also issued in the UK.

"We have been working on the continuous production of the microalga C. cohnii for a number of years, and this patent describes a process for the production of DHA using a continuous production process with an inexpensive feedstock," said Colin Ratledge of the University of Hull and primary inventor on the patent.

"Consistent with AFSG's multidisciplinary focus on developing new technologies for agro-raw materials, this patent describes a new method of producing DHA which is important in a number of human and animal nutrition applications," said Lolke Sijtsma of AFSG.

"ABN is focused on the fundamental requirement of DHA in nutrition, and since this new technology represents a novel way of producing this important molecule, we are excited to be the worldwide exclusive licensee," said David J. Kyle, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of ABN.

DHA is a critical building block of neurological tissues and has been commercialized as a key additive to infant formulas. Recent scientific publications have also identified the importance of DHA in neurological development of companion animals, fertility in thoroughbred racehorses, improvement of growth and fertility in swine, and growth of many aquacultured species, including shrimp and salmon. These animal applications are the primary commercial focus of ABN.

About ABN:

Advanced BioNutrition is a leader in developing functional ingredients, including DHA, to improve the health, nutrition and performance of animals, and new probiotic pro·bi·ot·ic
n.
A dietary supplement containing live bacteria or yeast that supplements normal gastrointestinal flora, given especially after depletion of flora caused by infection or ingestion of an antibiotic drug.
 technologies to improve animal and human health and wellness. The company is located in Columbia, MD. www.advancedbionutrition.com.

About the University of Hull and Professor Ratledge:

The University of Hull is an academic institution located in Hull, Great Britain, and is actively involved in a wide range of partnerships with organizations and businesses from the public and private sectors. Colin Ratledge is a professor in the Department of Biological Sciences whose research interests involve lipid biosynthesis Biosynthesis

The synthesis of more complex molecules from simpler ones in cells by a series of reactions mediated by enzymes. The overall economy and survival of the cell is governed by the interplay between the energy gained from the breakdown of compounds
 and the biotechnological production of polyunsaturated polyunsaturated /poly·un·sat·u·rat·ed/ (-un-sach´er-at-ed) denoting a chemical compound, particularly a fatty acid, having two or more double or triple bonds in its hydrocarbon chain.  oils. www.hull.ac.uk/biosci.

About Wageningen UR, Agrotechnology & Food Sciences Group (AFSG):

AFSG (previously known as ATO) is an organization for fundamental and applied-scientific research for agriculture and horticulture, trade and export, and for industries manufacturing food and non-food products on the basis of vegetable and animal raw materials. One of the main topics of research is the biobased economy in which renewable resources and their conversion to value added Value Added

The enhancement a company gives its product or service before offering the product to customers.

Notes:
This can either increase the products price or value.
 products play a vital role. Dr. Lolke Sijtsma is senior scientist with AFSG, and his research interests involve production of polyunsaturated oils and marine biotechnology. www.afsg.wur.nl.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 12, 2006
Words:525
Previous Article:Fitch Upgrades 2 Classes of NationsLink Funding Corp. 1999-1.
Next Article:Miami Herald Creative Director to Share Secrets of Successful Cross-Cultural Marketing at G. A. Wright Marketing Event in Denver.
Topics:



Related Articles
Two ARIAD Patents Issued On Drugs Targeting Human Gene Regulator Proteins; Potential New Therapies for Inflammatory, Immune, Cardiac, and Bone...
Advanced BioNutrition Closes $2.5 Million Series a Funding Round; Company focuses on rapidly growing worldwide animal health and nutrition market.
Advanced BioNutrition Corp.'s Latest Round of Funding is Co-Led by Sherbrooke Capital.
MINING PATENT DATABASE TRACKS PATENT INFRINGEMENT.
Count semiviable bacteria in cheese.
Advanced BioNutrition Completes Series A Financing With $2.5 Million Investment; Funding Will Speed Entry into Animal Health and Nutrition Market.
Advanced BioNutrition Announces Agreement with Martek for Sale of DHA into Aquaculture and Animal Health Markets.
Waggers Dog Treats Include Omega-3 DHA from ABN.
William F. Kirk Joins Advanced BioNutrition as CEO.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles